World's first biomarker-driven pain & metabolic clinic.
High-Sensitivity C-Reactive Protein (hs-CRP) is a blood biomarker used to detect very low levels of inflammation throughout the body. Unlike the standard CRP test, which identifies significant inflammation caused by infections or active inflammatory diseases, hs-CRP is designed to measure subtle, chronic inflammation that may not cause obvious symptoms.
Persistent low-grade inflammation has been linked to cardiovascular disease, metabolic disorders, obesity, diabetes, and several chronic musculoskeletal conditions. Measuring hs-CRP helps healthcare providers better understand a person's inflammatory status and identify potential health risks before symptoms become severe.
For individuals with arthritis, chronic pain, or metabolic health concerns, hs-CRP provides valuable insight into ongoing systemic inflammation.
High-Sensitivity C-Reactive Protein (hs-CRP) is an advanced laboratory test that measures extremely small amounts of C-Reactive Protein in the bloodstream.
Like standard CRP, hs-CRP reflects inflammation and is produced by the liver in response to inflammatory signals, particularly Interleukin-6 (IL-6). The difference lies in the sensitivity of the test. While standard CRP detects significant inflammation, hs-CRP measures much lower concentrations, making it useful for identifying chronic, low-grade inflammation.
This low-level inflammation is increasingly recognized as an important contributor to cardiovascular disease, metabolic dysfunction, and accelerated aging.
Unlike imaging tests that evaluate structural damage, hs-CRP provides insight into the body's overall inflammatory burden.
Chronic low-grade inflammation often develops silently over many years before symptoms appear.
Measuring hs-CRP helps healthcare providers:
Persistently elevated hs-CRP levels may indicate ongoing inflammation that warrants further medical evaluation.
| hs-CRP Level | Interpretation |
|---|---|
| Less than 1 mg/L | Low inflammation and lower cardiovascular risk |
| 1–3 mg/L | Mild chronic inflammation and moderate cardiovascular risk |
| Greater than 3 mg/L | High chronic inflammation and increased cardiovascular risk |
| Greater than 10 mg/L | Significant inflammation or infection; repeat testing may be recommended after recovery |
An hs-CRP level below 1 mg/L is generally considered ideal for long-term health.
Elevated hs-CRP suggests persistent low-grade inflammation somewhere in the body.
Common causes include:
A high hs-CRP level does not identify the exact source of inflammation but signals the need for further clinical evaluation.
Low hs-CRP levels are generally considered a positive sign and reflect healthy inflammatory balance.
There are no known health risks associated with having very low hs-CRP levels.
hs-CRP itself does not cause symptoms.
Symptoms depend on the underlying condition responsible for chronic inflammation.
Common symptoms include:
Some individuals with elevated hs-CRP may have no noticeable symptoms despite ongoing inflammation.
Several health conditions may increase hs-CRP levels.
Low-grade inflammation contributes to the development and progression of atherosclerosis and heart disease.
Excess body fat releases inflammatory chemicals that increase hs-CRP production.
Insulin resistance and chronic metabolic dysfunction frequently elevate hs-CRP.
Inflammatory and degenerative joint diseases may contribute to higher hs-CRP levels.
Smoking promotes chronic systemic inflammation and increases cardiovascular risk.
Long-term psychological stress can contribute to persistent low-grade inflammation.
Conditions such as rheumatoid arthritis and lupus commonly increase hs-CRP levels.
hs-CRP is widely used to estimate cardiovascular inflammatory risk.
Higher hs-CRP levels have been associated with:
hs-CRP is often interpreted alongside cholesterol levels, blood pressure, blood sugar, and other cardiovascular risk factors.
Persistent low-grade inflammation can negatively affect muscles, joints, tendons, and connective tissues.
Elevated hs-CRP has been associated with:
Reducing chronic inflammation may support both cardiovascular and musculoskeletal health.
hs-CRP is measured using a simple blood test.
Because even mild infections can temporarily increase hs-CRP, healthcare providers may recommend repeating the test if levels are above 10 mg/L after the acute illness has resolved.
Results are interpreted alongside:
Many individuals can reduce hs-CRP by addressing the underlying causes of chronic inflammation.
Moderate exercise helps reduce chronic inflammation and supports cardiovascular health.
Weight loss is often associated with meaningful reductions in hs-CRP.
Eating plenty of vegetables, fruits, whole grains, healthy fats, legumes, and omega-3-rich foods may help reduce chronic inflammation.
Consistent, restorative sleep supports healthy immune regulation and inflammatory balance.
Stopping smoking significantly lowers inflammation and improves cardiovascular health.
Effective treatment of diabetes, arthritis, obesity, hypertension, and autoimmune diseases often improves hs-CRP levels.
Yes. Both measure C-Reactive Protein, but hs-CRP detects much lower concentrations, making it useful for evaluating chronic low-grade inflammation and cardiovascular risk.
No. Elevated hs-CRP may result from obesity, diabetes, arthritis, autoimmune diseases, smoking, infections, or other inflammatory conditions.
No. hs-CRP is a supportive biomarker that must be interpreted alongside symptoms, medical history, physical examination, imaging, and other laboratory tests.
Your healthcare provider may recommend repeat hs-CRP testing to monitor cardiovascular risk, chronic inflammation, or response to lifestyle and medical interventions.
High-Sensitivity C-Reactive Protein (hs-CRP) is a valuable biomarker for detecting low-grade systemic inflammation that may contribute to cardiovascular disease, metabolic dysfunction, arthritis, and other chronic health conditions.
When interpreted alongside clinical findings and additional biomarkers, hs-CRP provides important insight into overall inflammatory health and supports personalized prevention and treatment strategies.